A lepidic gene signature predicts patient prognosis and sensitivity to immunotherapy in lung adenocarcinoma.
A lepidic gene signature predicts patient prognosis and sensitivity to immunotherapy in lung adenocarcinoma. Genome Med. 2022 01 12; 14(1):5.